Gemstone Biotherapeutics adds another wound-healing technology - Technical.ly Baltimore

Sciences

Feb. 26, 2016 12:26 pm

Gemstone Biotherapeutics adds another wound-healing technology

The addition of a treatment for diabetic foot ulcers is the company's second licensing deal from Johns Hopkins. “If it works like it did on animals, this is going to be really, really huge,” said CEO George Davis.

Gemstone's Matthew Davenport and Laura Dickinson accept an Incubator Company of the Year award.

(Courtesy photo)

Gemstone Biotherapeutics is looking to get a second treatment for wound care to the market.

The company licensed a product that is designed to specifically heal diabetic foot ulcers from Johns Hopkins University, said CEO George Davis. With the new addition to the portfolio, the Federal Hill-based company is looking to commercialize two products at once.

Davis said the company sees a big opportunity with the new technology, which was developed out of research led by Jeremy Walston and Peter Abadir in the Johns Hopkins School of Medicine.

The open sores that develop on the bottom of the foot affect about 15 percent of patients with diabetes, and can lead to amputations. The treatment that Gemstone licensed is a topical gel that reactivates a system of mitochondrial angiotensin receptors that weakens with age, and prohibits wounds from healing. It applies drugs that are currently used to treat hypertension to the wounds.

“It attacks the biology of what’s causing the wound not to heal,” Davis said. That enables the wounds to heal faster. That’s different from treatments currently on the market.

Davis said a large animal study has already been completed using the drug on pigs.

“If it works like it did on animals, this is going to be really, really huge,” he said.

Treatment is also costly for the healthcare system. According to a 2014 American Diabetes Association study, the wounds are a “burden” on hospitals that cost $9-13 billion in costs annually.

The new licensing deal adds a second product to the company’s portfolio. Gemstone started out developing a separate Hopkins-developed treatment that prevents scarring. Davis said the team will be able to apply what they learned over the last year and a half of initial stages in developing that product.

“They’ve learned so much about what it takes to move a product from the lab to a bedside application,” Davis said.

From a company perspective, the new deal indicates that the company isn’t “tied to one technology,” Davis said, but still focused on wound care.

Advertisement

Following a $2.45 million seed round that closed last summer, the company moved to offices in the same building that houses M.C. Dean in Federal Hill, and brought on former Johns Hopkins FastForward Venture Manager Ian Tolfree as director of operations.

“I think it gets us through mid-late 2017 on precipice of two turnkey solutions,” Davis said of the seed round.

You must appreciate accurate, relevant and productive community journalism.  Support this sort of work from professional reporters with seasoned editors.  Become a Technical.ly member for $12 per month -30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Following Boston accelerator, Pinkaloo launches charitable giving pilot with Eastern Bank

This Annapolis fintech startup wants to make it easier for banks to work with cannabis businesses

How law firm Nemphos Braue is guiding startups along the new business learning curve

SPONSORED

Baltimore

How law firm Nemphos Braue is guiding startups along the new business learning curve

Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now
Baltimore, MD

SmartLogic

Account Executive (Baltimore)

Apply Now
Baltimore

SchoolDuels

Vice President of Business Development

Apply Now

Hungry Harvest merges with North Carolina-based ugly produce delivery company

Biotech manufacturing center near BWI will have space to produce spinal muscular atrophy treatment

Genomics leader Illumina is opening a new center at University of Maryland BioPark

SPONSORED

Baltimore

Building a data acquisition system? Don’t make this mistake

Baltimore

emocha Mobile Health

Software Engineer

Apply Now
Baltimore

RackTop Systems

API Guru

Apply Now
Baltimore

Osmosis

Front End Developer

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!